PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS)

NCT06791031 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

212

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: PCSK9 inhibitor (PCSK9i)

Sponsor

West China Hospital